{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:46:00Z","timestamp":1793677560600,"version":"4.5.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R281-2018-131"],"award-info":[{"award-number":["R281-2018-131"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R281-2018-131"],"award-info":[{"award-number":["R281-2018-131"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R281-2018-131"],"award-info":[{"award-number":["R281-2018-131"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R281-2018-131"],"award-info":[{"award-number":["R281-2018-131"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R281-2018-131"],"award-info":[{"award-number":["R281-2018-131"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["8020-00414B"],"award-info":[{"award-number":["8020-00414B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["8020-00414B"],"award-info":[{"award-number":["8020-00414B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","award":["R216-A9684"],"award-info":[{"award-number":["R216-A9684"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","award":["R216-A9684"],"award-info":[{"award-number":["R216-A9684"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-00462"],"award-info":[{"award-number":["2021-00462"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Selective serotonin reuptake inhibitors (SSRIs) are widely used for treating neuropsychiatric disorders. However, the exact mechanism of action and why effects can take several weeks to manifest is not clear. The hypothesis of neuroplasticity is supported by preclinical studies, but the evidence in humans is limited. Here, we investigate the effects of the SSRI escitalopram on presynaptic density as a proxy for synaptic plasticity. In a double-blind placebo-controlled study (NCT04239339), 32 healthy participants with no history of psychiatric or cognitive disorders were randomized to receive daily oral dosing of either 20\u2009mg escitalopram (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200917) or a placebo (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200915). After an intervention period of 3\u20135 weeks, participants underwent a [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J PET scan (29 with full arterial input function) to quantify synaptic vesicle glycoprotein 2A (SV2A) density in the hippocampus and the neocortex. Whereas we find no statistically significant group difference in SV2A binding after an average of 29 (range: 24\u201338) days of intervention, our secondary analyses show a time-dependent effect of escitalopram on cerebral SV2A binding with positive associations between [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J binding and duration of escitalopram intervention. Our findings suggest that brain synaptic plasticity evolves over 3\u20135 weeks in healthy humans following daily intake of escitalopram. This is the first in vivo evidence to support the hypothesis of neuroplasticity as a mechanism of action for SSRIs in humans and it offers a plausible biological explanation for the delayed treatment response commonly observed in patients treated with SSRIs. While replication is warranted, these results have important implications for the design of future clinical studies investigating the neurobiological effects of SSRIs.\n                  <\/jats:p>","DOI":"10.1038\/s41380-023-02285-8","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:02:07Z","timestamp":1696831327000},"page":"4272-4279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-2368","authenticated-orcid":false,"given":"Annette","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Armand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Plav\u00e9n-Sigray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arafat","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Ozenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida N.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sune H.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7805-279X","authenticated-orcid":false,"given":"Vincent","family":"Beliveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-1072","authenticated-orcid":false,"given":"Kirsten","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Vassilieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-2820","authenticated-orcid":false,"given":"Christelle","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-1825","authenticated-orcid":false,"given":"Claus","family":"Svarer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea S.","family":"Stenb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-1745","authenticated-orcid":false,"given":"Barbara J.","family":"Sahakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-6866","authenticated-orcid":false,"given":"Gitte M.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"2285_CR1","doi-asserted-by":"publisher","first-page":"e0231700","DOI":"10.1371\/journal.pone.0231700","volume":"15","author":"FC Gabriel","year":"2020","unstructured":"Gabriel FC, Melo DOD, Fr\u00e1guas R, Leite-Santos NC, Silva RAMda, Ribeiro E. Pharmacological treatment of depression: a systematic review comparing clinical practice guideline recommendations. Plos One. 2020;15:e0231700.","journal-title":"Plos One"},{"key":"2285_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.psyneuen.2010.08.011","volume":"36","author":"I Branchi","year":"2011","unstructured":"Branchi I. The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrino. 2011;36:339\u201351.","journal-title":"Psychoneuroendocrino"},{"key":"2285_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nrn1256","volume":"4","author":"P Gaspar","year":"2003","unstructured":"Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci. 2003;4:1002\u201312.","journal-title":"Nat Rev Neurosci"},{"key":"2285_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41593-022-01213-3","volume":"26","author":"P Salvan","year":"2023","unstructured":"Salvan P, Fonseca M, Winkler AM, Beauchamp A, Lerch JP, Johansen-Berg H. Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks. Nat Neurosci. 2023;26:53\u201363.","journal-title":"Nat Neurosci"},{"key":"2285_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neubiorev.2017.03.007","volume":"77","author":"C Kraus","year":"2017","unstructured":"Kraus C, Castr\u00e9n E, Kasper S, Lanzenberger R. Serotonin and neuroplasticity \u2013 Links between molecular, functional and structural pathophysiology in depression. Neurosci Biobehav Rev. 2017;77:317\u201326.","journal-title":"Neurosci Biobehav Rev"},{"key":"2285_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338:68\u201372.","journal-title":"Science"},{"key":"2285_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1600-0447.2011.01744.x","volume":"124","author":"SD \u00d8stergaard","year":"2011","unstructured":"\u00d8stergaard SD, Jensen SOW, Bech P. The heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatr Scand. 2011;124:495\u20136.","journal-title":"Acta Psychiatr Scand"},{"key":"2285_CR8","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report. Am J Psychiat. 2006;163:1905\u201317.","journal-title":"Am J Psychiat"},{"key":"2285_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-04618-x","volume":"23","author":"KHR Jensen","year":"2023","unstructured":"Jensen KHR, Dam VH, Ganz M, Fisher PM, Ip C-T, Sankar A, et al. Deep phenotyping towards precision psychiatry of first-episode depression \u2014 the Brain Drugs-Depression cohort. BMC Psychiatry. 2023;23:151.","journal-title":"BMC Psychiatry"},{"key":"2285_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.npp.1301574","volume":"33","author":"C Pittenger","year":"2008","unstructured":"Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacol. 2008;33:88\u2013109.","journal-title":"Neuropsychopharmacol"},{"key":"2285_CR11","first-page":"57","volume":"32","author":"L Clark","year":"2009","unstructured":"Clark L, Chamberlain SR, Sahakian BJ. Neurocognitive mechanisms in depression: implications for treatment. Neuroscience. 2009;32:57\u201374.","journal-title":"Neuroscience"},{"key":"2285_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/npp.2011.183","volume":"37","author":"JP Roiser","year":"2012","unstructured":"Roiser JP, Elliott R, Sahakian BJ. Cognitive mechanisms of treatment in depression. Neuropsychopharmacol. 2012;37:117\u201336.","journal-title":"Neuropsychopharmacol"},{"key":"2285_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1150516","volume":"320","author":"JFM Vetencourt","year":"2008","unstructured":"Vetencourt JFM, Sale A, Viegi A, Baroncelli L, Pasquale RD, O\u2019Leary OF, et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008;320:385\u20138.","journal-title":"Science"},{"key":"2285_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2017.61","volume":"22","author":"E Castr\u00e9n","year":"2017","unstructured":"Castr\u00e9n E, Antila H. Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatr. 2017;22:1085\u201395.","journal-title":"Mol Psychiatr"},{"key":"2285_CR15","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.3390\/ijerph19127102","volume":"19","author":"J Malik","year":"2022","unstructured":"Malik J, Stemplewski R, Maciaszek J. The effect of juggling as dual-task activity on human neuroplasticity: a systematic review. Int J Environ Res Pu. 2022;19:7102.","journal-title":"Int J Environ Res Pu"},{"key":"2285_CR16","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin S, Chen M-K, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8:348ra96.","journal-title":"Sci Transl Med"},{"key":"2285_CR17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","volume":"75","author":"M-K Chen","year":"2018","unstructured":"Chen M-K, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin S, et al. Assessing synaptic density in alzheimer disease with synaptic vesicle glycoprotein 2a positron emission tomographic imaging. Jama Neurol. 2018;75:1215.","journal-title":"Jama Neurol"},{"key":"2285_CR18","doi-asserted-by":"publisher","first-page":"e037791","DOI":"10.1002\/alz.037791","volume":"16","author":"AP Mecca","year":"2020","unstructured":"Mecca AP, O\u2019Dell RS, Chen M, Naganawa M, Toyonaga T, Godek TA, et al. In vivo measurement of widespread synaptic loss and associated tau accumulation in early Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2020;16:e037791.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2285_CR19","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/alz.12582","volume":"18","author":"AP Mecca","year":"2022","unstructured":"Mecca AP, O\u2019Dell RS, Sharp ES, Banks ER, Bartlett HH, Zhao W, et al. Synaptic density and cognitive performance in Alzheimer\u2019s disease: A PET imaging study with [11C]UCB\u2010J. Alzheimer\u2019s Dement. 2022;18:2527\u201336.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2285_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09562-7","volume":"10","author":"SE Holmes","year":"2019","unstructured":"Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, et al. Lower synaptic density is associated with depression severity and network alterations. Nat Commun. 2019;10:1529.","journal-title":"Nat Commun"},{"key":"2285_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14122-0","volume":"11","author":"EC Onwordi","year":"2020","unstructured":"Onwordi EC, Halff EF, Whitehurst T, Mansur A, Cotel M-C, Wells L, et al. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun. 2020;11:246.","journal-title":"Nat Commun"},{"key":"2285_CR22","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/s41380-021-01184-0","volume":"26","author":"R Radhakrishnan","year":"2021","unstructured":"Radhakrishnan R, Skosnik PD, Ranganathan M, Naganawa M, Toyonaga T, Finnema S, et al. In vivo evidence of lower synaptic vesicle density in schizophrenia. Mol Psychiatr. 2021;26:7690\u20138.","journal-title":"Mol Psychiatr"},{"key":"2285_CR23","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/s41380-022-01465-2","volume":"27","author":"SE Holmes","year":"2022","unstructured":"Holmes SE, Finnema SJ, Naganawa M, DellaGioia N, Holden D, Fowles K, et al. Imaging the effect of ketamine on synaptic density (SV2A) in the living brain. Mol Psychiatr. 2022;27:2273\u201381.","journal-title":"Mol Psychiatr"},{"key":"2285_CR24","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/S0033291716000064","volume":"46","author":"T Kishimoto","year":"2016","unstructured":"Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, et al. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med. 2016;46:1459\u201372.","journal-title":"Psychol Med"},{"key":"2285_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.npp.1300004","volume":"28","author":"CJ Harmer","year":"2003","unstructured":"Harmer CJ, Bhagwagar Z, Perrett DI, V\u00f6llm BA, Cowen PJ, Goodwin GM. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacol. 2003;28:148\u201352.","journal-title":"Neuropsychopharmacol"},{"key":"2285_CR26","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1038\/s41386-018-0229-z","volume":"43","author":"N Skandali","year":"2018","unstructured":"Skandali N, Rowe JB, Voon V, Deakin JB, Cardinal RN, Cormack F, et al. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans. Neuropsychopharmacol. 2018;43:2645\u201351.","journal-title":"Neuropsychopharmacol"},{"key":"2285_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16090-2","volume":"11","author":"J Michely","year":"2020","unstructured":"Michely J, Eldar E, Martin IM, Dolan RJ. A mechanistic account of serotonin\u2019s impact on mood. Nat Commun. 2020;11:2335.","journal-title":"Nat Commun"},{"key":"2285_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/01.yic.0000074988.54339.7c","volume":"18","author":"UM Lepola","year":"2003","unstructured":"Lepola UM, Loft H, Reines EH. Escitalopram (10\u201320 mg\/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharm. 2003;18:211\u20137.","journal-title":"Int Clin Psychopharm"},{"key":"2285_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/01.yic.0000194375.42589.c3","volume":"21","author":"S Kasper","year":"2006","unstructured":"Kasper S, Spadone C, Verpillat P, Angst J. Onset of action of escitalopram compared with other antidepressants&colon; results of a pooled analysis. Int Clin Psychopharm. 2006;21:105\u201310.","journal-title":"Int Clin Psychopharm"},{"key":"2285_CR30","unstructured":"Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, et al. Practice guideline for the treatment of patients with major depressive disorder. American Psychiatric Association. 2010. 3rd ed. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf. Accessed Sep 6, 2022."},{"key":"2285_CR31","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","volume":"63","author":"MJ Taylor","year":"2006","unstructured":"Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiat. 2006;63:1217\u201323.","journal-title":"Arch Gen Psychiat"},{"key":"2285_CR32","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41398-022-02240-1","volume":"12","author":"VH Dam","year":"2022","unstructured":"Dam VH, Stenb\u00e6k DS, K\u00f6hler-Forsberg K, Ip C, Ozenne B, Sahakian BJ, et al. Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: a NeuroPharm study. Transl Psychiat. 2022;12:468.","journal-title":"Transl Psychiat"},{"key":"2285_CR33","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41386-022-01523-x","volume":"48","author":"C Langley","year":"2023","unstructured":"Langley C, Armand S, Luo Q, Savulich G, Segerberg T, S\u00f8ndergaard A, et al. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study. Neuropsychopharmacol. 2023;48:664\u201370.","journal-title":"Neuropsychopharmacol"},{"key":"2285_CR34","unstructured":"Reynolds CR, Kamphaus RW. Introduction to the Reynolds Intellectual Assessment Scales and the Reynolds Intellectual Screening Test. Contemporary intellectual assessment: theories, tests, and issues., New York, NY, US: The Guilford Press; 2005. p. 461\u201383."},{"key":"2285_CR35","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1177\/0271678X17724947","volume":"38","author":"SJ Finnema","year":"2017","unstructured":"Finnema SJ, Nabulsi NB, Mercier J, Lin S, Chen M-K, Matuskey D, et al. Kinetic evaluation and test\u2013retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans. J Cereb Blood Flow Metab. 2017;38:2041\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2285_CR36","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B. FreeSurfer. Neuroimage 2012;62:774\u201381.","journal-title":"Neuroimage"},{"key":"2285_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2967\/jnumed.115.168179","volume":"57","author":"NB Nabulsi","year":"2016","unstructured":"Nabulsi NB, Mercier J, Holden D, Carr\u00e9 S, Najafzadeh S, Vandergeten M-C, et al. Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J Nucl Med. 2016;57:777\u201384.","journal-title":"J Nucl Med"},{"key":"2285_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1109\/TMI.2007.892644","volume":"26","author":"IK Hong","year":"2007","unstructured":"Hong IK, Chung ST, Kim HK, Kim YB, Son YD, Cho ZH. Ultra fast symmetry and SIMD-based projection-backprojection (SSP) algorithm for 3-D PET image reconstruction. IEEE Trans Med Imaging. 2007;26:789\u2013803.","journal-title":"IEEE Trans Med Imaging"},{"key":"2285_CR39","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2967\/jnumed.107.045351","volume":"49","author":"FC Sureau","year":"2008","unstructured":"Sureau FC, Reader AJ, Comtat C, Leroy C, Ribeiro M-J, Buvat I, et al. Impact of image-space resolution modeling for studies with the high-resolution research tomograph. J Nucl Med. 2008;49:1000\u20138.","journal-title":"J Nucl Med"},{"key":"2285_CR40","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1109\/TMI.2013.2261313","volume":"32","author":"SH Keller","year":"2013","unstructured":"Keller SH, Svarer C, Sibomana M. Attenuation correction for the HRRT PET-scanner using transmission scatter correction and total variation regularization. IEEE Trans Med Imaging. 2013;32:1611\u201321.","journal-title":"IEEE Trans Med Imaging"},{"key":"2285_CR41","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neuroimage.2004.10.017","volume":"24","author":"C Svarer","year":"2005","unstructured":"Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugb\u00f8l S, Fr\u00f8kj\u00e6r VG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005;24:969\u201379.","journal-title":"Neuroimage"},{"key":"2285_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00664-8","volume":"10","author":"J Tjerkaski","year":"2020","unstructured":"Tjerkaski J, Cervenka S, Farde L, Matheson GJ. Kinfitr \u2014 an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability. EJNMMI Res. 2020;10:77.","journal-title":"EJNMMI Res"},{"key":"2285_CR43","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1177\/0271678X19879230","volume":"40","author":"S Rossano","year":"2019","unstructured":"Rossano S, Toyonaga T, Finnema SJ, Naganawa M, Lu Y, Nabulsi N, et al. Assessment of a white matter reference region for 11C-UCB-J PET quantification. J Cereb Blood Flow Metab.2019;40:1890\u2013901.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2285_CR44","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/epi.14701","volume":"60","author":"SJ Finnema","year":"2019","unstructured":"Finnema SJ, Rossano S, Naganawa M, Henry S, Gao H, Pracitto R, et al. A single\u2010center, open\u2010label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers. Epilepsia. 2019;60:958\u201367.","journal-title":"Epilepsia"},{"key":"2285_CR45","first-page":"87","volume":"50","author":"SR Lipsitz","year":"2001","unstructured":"Lipsitz SR, Leong T, Ibrahim J, Lipshultz S. A partial correlation coefficient and coefficient of determination for multivariate normal repeated measures data. J R Stat Soc: Ser D (Stat). 2001;50:87\u201395.","journal-title":"J R Stat Soc: Ser D (Stat)"},{"key":"2285_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","volume":"4","author":"CJ Harmer","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017;4:409\u201318.","journal-title":"Lancet Psychiatry"},{"key":"2285_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41380-021-01285-w","volume":"27","author":"A S\u00f8rensen","year":"2022","unstructured":"S\u00f8rensen A, Ruh\u00e9 HG, Munkholm K. The relationship between dose and serotonin transporter occupancy of antidepressants\u2014a systematic review. Mol Psychiatr. 2022;27:192\u2013201.","journal-title":"Mol Psychiatr"},{"key":"2285_CR48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jnc.14114","volume":"142","author":"S Fritze","year":"2017","unstructured":"Fritze S, Spanagel R, Noori HR. Adaptive dynamics of the 5\u2010HT systems following chronic administration of selective serotonin reuptake inhibitors: a meta\u2010analysis. J Neurochem. 2017;142:747\u201355.","journal-title":"J Neurochem"},{"key":"2285_CR49","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1460-9568.2005.03968.x","volume":"21","author":"T Hajszan","year":"2005","unstructured":"Hajszan T, MacLusky NJ, Leranth C. Short\u2010term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci. 2005;21:1299\u2013303.","journal-title":"Eur J Neurosci"},{"key":"2285_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-011-2463-5","volume":"219","author":"H Zhong","year":"2012","unstructured":"Zhong H, Haddjeri N. S\u00e1nchez C. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter\u2014a review of current understanding of its mechanism of action. Psychopharmacology. 2012;219:1\u201313.","journal-title":"Psychopharmacology"},{"key":"2285_CR51","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 2021;184:1299\u20131313.e19.","journal-title":"Cell"},{"key":"2285_CR52","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/ijms22020835","volume":"22","author":"NR Raval","year":"2021","unstructured":"Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, et al. A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain. Int J Mol Sci. 2021;22:835.","journal-title":"Int J Mol Sci"},{"key":"2285_CR53","doi-asserted-by":"publisher","first-page":"e13123","DOI":"10.1111\/adb.13123","volume":"27","author":"GA Angarita","year":"2022","unstructured":"Angarita GA, Worhunsky PD, Naganawa M, Toyonaga T, Nabulsi NB, Li CR, et al. Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory 11C\u2010UCB\u2010J positron emission tomography study in humans. Addict Biol. 2022;27:e13123.","journal-title":"Addict Biol"},{"key":"2285_CR54","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1038\/s41380-020-00891-4","volume":"26","author":"DC D\u2019Souza","year":"2021","unstructured":"D\u2019Souza DC, Radhakrishnan R, Naganawa M, Ganesh S, Nabulsi N, Najafzadeh S, et al. Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder. Mol Psychiatr. 2021;26:3192\u20133200.","journal-title":"Mol Psychiatr"},{"key":"2285_CR55","doi-asserted-by":"publisher","first-page":"e22157","DOI":"10.1002\/syn.22157","volume":"74","author":"K Varn\u00e4s","year":"2020","unstructured":"Varn\u00e4s K, Stepanov V, Halldin C. Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non\u2010human primate and human brain. Synapse. 2020;74:e22157.","journal-title":"Synapse"},{"key":"2285_CR56","doi-asserted-by":"publisher","first-page":"eaaw9997","DOI":"10.1126\/science.aaw9997","volume":"366","author":"P Guedes-Dias","year":"2019","unstructured":"Guedes-Dias P, Holzbaur ELF. Axonal transport: driving synaptic function. Science. 2019;366:eaaw9997.","journal-title":"Science"},{"key":"2285_CR57","doi-asserted-by":"publisher","first-page":"118167","DOI":"10.1016\/j.neuroimage.2021.118167","volume":"237","author":"XT Fang","year":"2021","unstructured":"Fang XT, Toyonaga T, Hillmer AT, Matuskey D, Holmes SE, Radhakrishnan R, et al. Identifying brain networks in synaptic density PET (11C-UCB-J) with independent component analysis. Neuroimage. 2021;237:118167.","journal-title":"Neuroimage"},{"key":"2285_CR58","doi-asserted-by":"publisher","first-page":"1124254","DOI":"10.3389\/fnhum.2023.1124254","volume":"17","author":"XT Fang","year":"2023","unstructured":"Fang XT, Volpi T, Holmes SE, Esterlis I, Carson RE, Worhunsky PD. Linking resting-state network fluctuations with systems of coherent synaptic density: a multimodal fMRI and 11C-UCB-J PET study. Front Hum Neurosci. 2023;17:1124254.","journal-title":"Front Hum Neurosci"},{"key":"2285_CR59","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/0271678X20964248","volume":"41","author":"H Tuncel","year":"2020","unstructured":"Tuncel H, Boellaard R, Coomans EM, Vries EFde, Glaudemans AW, Feltes PK, et al. Kinetics and 28-day test\u2013retest repeatability and reproducibility of [11C]UCB-J PET brain imaging. J Cereb Blood Metab. 2020;41:1338\u201350.","journal-title":"J Cereb Blood Metab"},{"key":"2285_CR60","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.neuroimage.2015.04.025","volume":"124","author":"GM Knudsen","year":"2016","unstructured":"Knudsen GM, Jensen PS, Erritzoe D, Baar\u00e9 WFC, Ettrup A, Fisher PM, et al. The center for integrated molecular brain imaging (Cimbi) database. NeuroImage. 2016;124:1213\u20139.","journal-title":"NeuroImage."}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02285-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02285-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02285-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T05:03:56Z","timestamp":1706591036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02285-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2285"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02285-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2989150\/v1","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"27 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GMK has received honoraria as a speaker for Sage Biogen and H. Lundbeck, and is a consultant for Onsero, Pangea, and Gilgamesh, Abbvie, PureTechHealth. BJS consults for Cambridge Cognition and receives technology transfer fees from PopReach via Cambridge Enterprise. All other authors declare no competing interests. Funding agencies did not impact the study and played no role in manuscript preparation and submission.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}